{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:57:59Z","timestamp":1789408679799,"version":"build-2803163510"},"reference-count":19,"publisher":"Microbiology Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"abstract":"<jats:p>The envelope glycoprotein G of rabies virus in vaccines induces the production of neutralizing antibodies important in the protection against the disease. The measurement of anti-envelope glycoprotein antibodies is a good predictor of the degree of humoral immunity in people during anti-rabies treatment or after vaccination. Several assays exist for the serological determination of antibody protection against rabies virus infection. Antibody neutralization by the rapid fluorescent focus inhibition test (RFFIT) or the fluorescent antibody virus neutralization (FAVN) test is currently the gold standard. Performance of the highly complex RFFIT and FAVN tests, however, requires specialized reference laboratories with expertise with this assay. Although not widely used, ELISA test kits are available and may be an additional option for testing that is more accessible. The aim of the present study was to evaluate available ELISA assays for the determination of anti-rabies antibodies. We compared the Bio-Rad Platelia Rabies II ELISA, DRG Rabies Virus IgG Ab ELISA and Focus Diagnostics Rabies Antibody Detection by ELISA to RFFIT. Bland\u2013Altman plots comparing the Bio-Rad Platelia assay and the Focus Diagnostics assay to RFFIT showed a low degree of variability between the ELISA assays and RFFIT results except in samples with high RFFIT values. The agreement, sensitivity and specificity of Bio-Rad Platelia Rabies II ELISA when compared to RFFIT were 95.1\u200a%, 94.1\u200a% and 95.8\u200a%, respectively. The DRG Rabies assay compared to RFFIT had an agreement of 77.7\u200a%, a sensitivity of 86.7\u200a% and a specificity of 69.4\u200a%. The agreement, sensitivity and specificity of Focus Diagnostics Rabies Detection by ELISA when compared to RFFIT were 82.2\u200a%, 91.7\u200a% and 73.0\u200a%, respectively. Overall, the Bio-Rad Platelia assay showed higher accuracy and specificity than either the DRG or Focus assays. All of these ELISAs, however, measure all antibody types and do not discriminate the neutralizing antibodies as measured by functional assays (RFFIT and FAVN) and cannot be relied upon to predict the neutralizing activity of the sera. The results of this study offer insight into the availability of alternative, less-complex methods to monitor rabies antibody titres in at-risk individuals following vaccination.<\/jats:p>","DOI":"10.1099\/jmm.0.006064-0","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T17:23:51Z","timestamp":1241803431000},"page":"806-810","source":"Crossref","is-referenced-by-count":56,"title":["An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies"],"prefix":"10.1099","volume":"58","author":[{"given":"Ryan J.","family":"Welch","sequence":"first","affiliation":[{"name":"Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Litwin","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah, Salt Lake City, UT, USA"},{"name":"Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","first-page":"257","article-title":"Micromethod for rabies antibody detection by immunoenzymatic assay with Staphylococcus protein A","volume":"130","author":"Atanasiu","year":"1979","journal-title":"Ann Microbiol (Paris"},{"key":"R2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","article-title":"Comparing methods of measurement: why plotting difference against standard method is misleading","volume":"346","author":"Bland","year":"1995","journal-title":"Lancet"},{"key":"R3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/biol.1998.0162","article-title":"A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas","volume":"26","author":"Briggs","year":"1998","journal-title":"Biologicals"},{"key":"R4","first-page":"1","article-title":"Human rabies prevention \u2013 United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5","first-page":"1","article-title":"Compendium of Animal Rabies Prevention and Control","volume":"55","year":"2006","journal-title":"(NASPHV). MMWR Morb Mortal Wkly Rep"},{"key":"R6","article-title":"Rabies virus maintained by dogs in humans and terrestrial wildlife","author":"Favoretto","year":"2006"},{"key":"R7","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","article-title":"Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM199311253292208","article-title":"Rabies","volume":"329","author":"Fishbein","year":"1993","journal-title":"N Engl J Med"},{"key":"R9","volume-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1981"},{"key":"R10","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"R11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3201\/eid1105.041289","article-title":"Travel-associated rabies in Austrian man","volume":"11","author":"Krause","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R12","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2460\/javma.2005.227.1912","article-title":"Rabies surveillance in the United States during 2004","volume":"227","author":"Krebs","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"R13","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Mandell","year":"2005"},{"key":"R14","first-page":"1","article-title":"Rationale and prospects for rabies elimination in developing countries","volume":"187","author":"Meslin","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2460\/javma.2000.216.188","article-title":"Decision-based evaluation of recommendations for preexposure rabies vaccination","volume":"216","author":"Murray","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"R16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-1157(86)90027-2","article-title":"The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus","volume":"14","author":"Perrin","year":"1986","journal-title":"J Biol Stand"},{"key":"R17","first-page":"1","article-title":"WHO Expert Consultation on rabies","volume":"931","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1086\/375605","article-title":"Rabies update for travel medicine advisors","volume":"37","author":"Wilde","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R19","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison","volume":"89","author":"Wright","year":"2008","journal-title":"J Gen Virol"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.006064-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T07:18:04Z","timestamp":1601277484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.006064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.006064-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}